Please try another search
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company’s product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
John Irving Bell | 70 | 2015 | Independent Non-Executive Chairman |
Bahija Jallal | 63 | 2019 | CEO & Executive Director |
Roy Steven Herbst | 61 | 2021 | Independent Non-Executive Director |
Kristine Peterson | 65 | 2017 | Independent Non-Executive Director |
Robert J. Perez | 60 | 2019 | Independent Non-Executive Director |
Travis A. Coy | 44 | 2019 | Independent Non-Executive Director |
Peter J. Ratcliffe | 70 | 2020 | Independent Non-Executive Director |
Siddharth Kaul | 64 | 2022 | Independent Non-Executive Director |
Ranjeev Krishana | 50 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review